ALB and renal carcinoma: Albumin-to-alkaline phosphatase ratio (AAPR) is the ratio of serum albumin to alkaline phosphatase, and its predictive value for patients' prognosis has been confirmed in many malignant tumors, including non-small cell lung cancer, renal cancer, and nasopharyngeal carcinoma [17–19].